Equity Analysis

Quarterly Results

    Ipca Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524494
    INE571A01038
    265.6081351
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    IPCALAB
    56.13
    39157.98
    EPS(TTM)
    Face Value()
    Div & Yield %:
    27.5
    1
    0.26
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales1810.941565.861510.62
Other Operating Income0.000.000.00
Other Income 17.0015.3915.10
Total Income1827.941581.251525.72
Total Expenditure 1408.831212.621312.60
PBIDT419.11368.63213.12
Interest 17.2519.4224.06
PBDT401.86349.21189.06
Depreciation62.6561.3261.76
Tax94.5081.0061.91
Fringe Benefit Tax0.000.000.00
Deferred Tax0.592.760.63
Reported Profit After Tax244.12204.1364.76
Extra-ordinary Items 0.000.00-47.98
Adjusted Profit After Extra-ordinary item244.12204.13112.74
EPS (Unit Curr.)9.628.052.55
EPS (Adj) (Unit Curr.)9.628.052.55
Calculated EPS (Unit Curr.)9.628.052.55
Calculated EPS (Adj) (Unit Curr.)9.628.052.55
Calculated EPS (Ann.) (Unit Curr.)38.4932.1810.21
Calculated EPS (Adj) (Ann.) (Unit Curr.)38.4932.1810.21
Book Value (Unit Curr.)0.000.000.00
Dividend (%)200.000.000.00
Equity25.3725.3725.37
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)23.1423.5414.11
PBDTM(%)22.1922.3012.52
PATM(%)13.4813.044.29
Dividend Per Share(Rs)2.000.000.00
Diluted EPS9.628.052.55